drugset / Trial / NCT00292344
Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea
Phase 4
Completed
316 enrolled
The University of Texas Health Science Center, Houston
Bausch Health Americas, Inc. · collab
RandomizedSingle-groupDouble-blindTreatment
Summary
Most cases of travelers' diarrhea are caused by bacterial pathogens which respond slowly to antibiotic treatment.The study was designed to determine the value of rapidly acting loperamide (imodium) combined with curative dose of the poorly absorbed rifaximin in travelers' diarreha treatment.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loperamide | Small molecule | 2 mg | — |
| Subject | Rifaximin | Other / unclassified | 200 mg | — |